Back to top
more

Sabra Healthcare REIT (SBRA)

(Real Time Quote from BATS)

$18.39 USD

18.39
1,193,211

-0.02 (-0.11%)

Updated Aug 5, 2025 11:50 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (98 out of 246)

Industry: REIT and Equity Trust - Other

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Compared to Estimates, Sabra (SBRA) Q1 Earnings: A Look at Key Metrics

by Zacks Equity Research

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Exploring Analyst Estimates for Sabra (SBRA) Q1 Earnings, Beyond Revenue and EPS

by Zacks Equity Research

Evaluate the expected performance of Sabra (SBRA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Equity Research

Sabra (SBRA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Sabra Healthcare (SBRA) Lags Q4 FFO and Revenue Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of -2.94% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ahead of Sabra (SBRA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Sabra (SBRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Zacks Equity Research

Alexander's (ALX) Lags Q4 FFO Estimates

by Zacks Equity Research

Alexander's (ALX) delivered FFO and revenue surprises of -16.13% and 13.60%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for KBWY

Zacks Equity Research

Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Lamar Advertising (LAMR) Beats Q3 FFO Estimates

by Zacks Equity Research

Lamar (LAMR) delivered FFO and revenue surprises of 6.81% and 0.16%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for KBWY

Zacks Equity Research

Sabra (SBRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Sabra Healthcare (SBRA) Q2 FFO Meet Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 0% and 1.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

CubeSmart (CUBE) Q2 FFO and Revenues Lag Estimates

by Zacks Equity Research

CubeSmart (CUBE) delivered FFO and revenue surprises of -1.49% and 0.62%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Summit Hotel Properties (INN) Q2 FFO and Revenues Top Estimates

by Zacks Equity Research

Summit Hotel Properties (INN) delivered FFO and revenue surprises of 28.57% and 1.91%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Sabra (SBRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Sabra Healthcare (SBRA) Matches Q1 FFO Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 0% and 1.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Welltower (WELL) Q1 FFO and Revenues Beat Estimates

by Zacks Equity Research

Welltower (WELL) delivered FFO and revenue surprises of 3.66% and 1.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Stag Industrial (STAG) Meets Q1 FFO Estimates

by Zacks Equity Research

Stag (STAG) delivered FFO and revenue surprises of 0% and 1.96%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Implied Volatility Surging for Sabra Healthcare REIT (SBRA) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Sabra Healthcare REIT (SBRA) stock based on the movements in the options market lately.

Zacks Equity Research

Implied Volatility Surging for Sabra Health Care (SBRA) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Sabra Health Care (SBRA) stock based on the movements in the options market lately.

Zacks Equity Research

Sabra Healthcare (SBRA) Beats Q4 FFO and Revenue Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 2.78% and 2.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Sabra Healthcare (SBRA) Q3 FFO and Revenues Miss Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of -5.26% and 10.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Americold Realty Trust Inc. (COLD) Surpasses Q3 FFO Estimates

by Zacks Equity Research

Americold Realty Trust Inc. (COLD) delivered FFO and revenue surprises of 16% and 0.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Park Hotels & Resorts (PK) Q3 FFO and Revenues Surpass Estimates

by Zacks Equity Research

Park Hotels & Resorts (PK) delivered FFO and revenue surprises of 5% and 1.59%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Industrial Logistics Properties Trust (ILPT) Lags Q3 FFO and Revenue Estimates

by Zacks Equity Research

Industrial Logistics Properties Trust (ILPT) delivered FFO and revenue surprises of -30.30% and 1.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?